Renaissance Technologies
NERV icon

Renaissance Technologies’s Minerva Neurosciences NERV Stock Holding History

Renaissance Technologies’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$540K Sell
89,700
-59,500
-40% -$341K ﹤0.01% 2571
2025
Q4 		$600K Buy
149,200
+32,700
+28% +$121K ﹤0.01% 2505
2025
Q3 		$245K Buy
116,500
+5,500
+5% +$11.2K ﹤0.01% 3078
2025
Q2 		$191K Sell
111,000
-3,097
-3% -$5.06K ﹤0.01% 3182
2025
Q1 		$194K Sell
114,097
-14,003
-11% -$27.6K ﹤0.01% 3082
2024
Q4 		$285K Sell
128,100
-29,100
-19% -$68.7K ﹤0.01% 3058
2024
Q3 		$420K Sell
157,200
-10,500
-6% -$30.5K ﹤0.01% 2860
2024
Q2 		$535K Sell
167,700
-10,065
-6% -$27.3K ﹤0.01% 2661
2024
Q1 		$459K Buy
177,765
+70,565
+66% +$433K ﹤0.01% 2900
2023
Q4 		$659K Buy
107,200
+13,000
+14% +$74.3K ﹤0.01% 2645
2023
Q3 		$650K Sell
94,200
-4,100
-4% -$36.7K ﹤0.01% 2588
2023
Q2 		$898K Sell
98,300
-12,500
-11% -$66K ﹤0.01% 2536
2023
Q1 		$177K Buy
110,800
+500
+0.5% +$1.03K ﹤0.01% 3329
2022
Q4 		$175K Buy
110,300
+8,500
+8% +$36.7K ﹤0.01% 3467
2022
Q3 		$940K Buy
101,800
+66,189
+186% +$392K ﹤0.01% 2538
2022
Q2 		$118K Sell
35,611
-13,133
-27% -$53.7K ﹤0.01% 3804
2022
Q1 		$324K Sell
48,744
-25,144
-34% -$154K ﹤0.01% 3436
2021
Q4 		$473K Sell
73,888
-20,377
-22% -$192K ﹤0.01% 3106
2021
Q3 		$1.31M Sell
94,265
-30,966
-25% -$466K ﹤0.01% 2395
2021
Q2 		$2.32M Buy
125,231
+70,343
+128% +$1.51M ﹤0.01% 2158
2021
Q1 		$1.28M Sell
54,888
-30,893
-36% -$772K ﹤0.01% 2493
2020
Q4 		$1.61M Buy
85,781
+4,818
+6% +$121K ﹤0.01% 2258
2020
Q3 		$2.06M Sell
80,963
-8,725
-10% -$236K ﹤0.01% 2111
2020
Q2 		$2.59M Buy
89,688
+1,675
+2% +$98.3K ﹤0.01% 2030
2020
Q1 		$4.24M Sell
88,013
-5,612
-6% -$339K ﹤0.01% 1667
2019
Q4 		$5.33M Buy
93,625
+4,100
+5% +$181K ﹤0.01% 1812
2019
Q3 		$5.55M Buy
89,525
+7,500
+9% +$425K ﹤0.01% 1732
2019
Q2 		$3.69M Buy
82,025
+16,587
+25% +$830K ﹤0.01% 1993
2019
Q1 		$4.12M Buy
65,438
+8,988
+16% +$540K ﹤0.01% 1931
2018
Q4 		$3.04M Buy
56,450
+18,550
+49% +$1.36M ﹤0.01% 2021
2018
Q3 		$3.81M Buy
37,900
+15,900
+72% +$1.19M ﹤0.01% 1969
2018
Q2 		$1.45M Buy
22,000
+15,550
+241% +$944K ﹤0.01% 2435
2018
Q1 		$323K Sell
6,450
-1,938
-23% -$93.1K ﹤0.01% 3053
2017
Q4 		$406K Sell
8,388
-17,312
-67% -$858K ﹤0.01% 2932
2017
Q3 		$1.56M Buy
25,700
+23,850
+1,289% +$1.37M ﹤0.01% 2398
2017
Q2 		$131K Sell
1,850
-6,863
-79% -$444K ﹤0.01% 3053
2017
Q1 		$565K Buy
8,713
+6,663
+325% +$517K ﹤0.01% 2735
2016
Q4 		$193K Sell
2,050
-19,013
-90% -$1.94M ﹤0.01% 3015
2016
Q3 		$2.38M Sell
21,063
-4,137
-16% -$401K ﹤0.01% 2079
2016
Q2 		$2.06M Buy
25,200
+21,525
+586% +$1.37M ﹤0.01% 2177
2016
Q1 		$181K Buy
+3,675
New +$157K ﹤0.01% 3115

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM

Renaissance Technologies's NERV Position: Q1 2026 in Review

Renaissance Technologies reduced its Minerva Neurosciences (NERV) stake by 40% in Q1 2026, selling an estimated $341K and leaving 89,700 shares worth $540K. The position accounts for ﹤0.01% of the portfolio, ranked #2571.

Renaissance Technologies first reported a position in NERV in Q1 2016 and has held it in 41 quarters since. The position peaked at $5.55M in Q3 2019. 47 funds tracked by Wall St. Rank hold NERV as of Q1 2026.

  • Renaissance Technologies held 89,700 shares of Minerva Neurosciences worth $540K as of Q1 2026.
  • Renaissance Technologies sold 59,500 Minerva Neurosciences shares in Q1 2026, an estimated $341K.
  • Minerva Neurosciences made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2571 holding.
  • Renaissance Technologies first reported a position in Minerva Neurosciences in Q1 2016 and has held it in 41 quarters since.
  • Renaissance Technologies's Minerva Neurosciences position peaked at $5.55M in Q3 2019.
  • 47 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.